DRUG DELIVERY DEVICE, METHOD OF MANUFACTURE, AND METHOD OF USE

Disclosed herein is a wearable drug delivery device including a container filled at least partially with a drug including at least one of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) specific antibody, a granulocyte colony-stimulating factor CSF), a sclerostin antibody, or a calcitonin ge...

Full description

Saved in:
Bibliographic Details
Main Authors Dardani, Ian P, Beaver, Scott, Feldman, Danielle, Destefano, Mark A, Codd, Daniel S, Bokelman, Kevin L, Ramaswamy, Rajan, Hanson, Ian B, Ubach, Antonio, Love, John C, Bente, IV, Paul F, Gibson, Scott Robert, Taha, Basel Hasan, Boyaval, Margaux Frances, Clemente, Matthew J, Laurence, Lawton, Moberg, Sheldon B, O'connor, Sean M
Format Patent
LanguageEnglish
Published 08.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed herein is a wearable drug delivery device including a container filled at least partially with a drug including at least one of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) specific antibody, a granulocyte colony-stimulating factor CSF), a sclerostin antibody, or a calcitonin gene-related peptide (CGRP) antibody. The wearable drug delivery device includes a needle and an insertion mechanism configured to insert the needle into a patient. A fluid pathway connector defines a sterile fluid flowpath between the container and the insertion mechanism. A cannula initially disposed about the needle is included.
Bibliography:Application Number: US201716089685